06:05 EDT ZyVersa Therapeutics (ZVSA) files to sell 17.5M shares of common stock for holders
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZVSA:
- ZyVersa announces first clinical site activation in VAR 200 Phase 2a trial
- ZyVersa Therapeutics Secures $10M Equity Purchase Agreement
- ZyVersa Therapeutics announcs share purchase agreement for up to $10M
- ZyVersa Therapeutics Stockholders Approve Key Proposals
- ZyVersa Therapeutics Reports Q1 2025 Financial Results